Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Changes in albumin excretion in the diabetes prevention program.

    Diabetes Prevention Program Research Group.

    Diabetes Care. 2009 Apr;32(4):720-5. Epub 2009 Jan 8.PMID: 19131464 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.

    Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R; Diabetes Prevention Program.

    Diabetes. 2008 Apr;57(4):980-6. Epub 2008 Jan 11.PMID: 18192541 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Value of urinary albumin-to-creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals.

    Friedman AN, Marrero D, Ma Y, Ackermann R, Narayan KM, Barrett-Connor E, Watson K, Knowler WC, Horton ES; Diabetes Prevention Program Research Group.

    Diabetes Care. 2008 Dec;31(12):2344-8. Epub 2008 Sep 16. Erratum in: Diabetes Care. 2009 May;32(5):968.. Friedman, Allon [corrected to Friedman, Allon N]. PMID: 18796622 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

    Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, Temprosa M; Diabetes Prevention Program Research Group.

    Diabetes Care. 2005 Apr;28(4):888-94.PMID: 15793191 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.

    Imano E, Kanda T, Nakatani Y, Nishida T, Arai K, Motomura M, Kajimoto Y, Yamasaki Y, Hori M.

    Diabetes Care. 1998 Dec;21(12):2135-9.PMID: 9839106 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.

    Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, Haffner SM, Price DW, Knowler WC; Diabetes Prevention Program Research Group.

    Diabetes Care. 2008 Mar;31(3):420-6. Epub 2007 Dec 10.PMID: 18071002 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

    Perreault L, Ma Y, Dagogo-Jack S, Horton E, Marrero D, Crandall J, Barrett-Connor E; Diabetes Prevention Program.

    Diabetes Care. 2008 Jul;31(7):1416-21. Epub 2008 Mar 20.PMID: 18356403 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study.

    Maahs DM, Snively BM, Bell RA, Dolan L, Hirsch I, Imperatore G, Linder B, Marcovina SM, Mayer-Davis EJ, Pettitt DJ, Rodriguez BL, Dabelea D.

    Diabetes Care. 2007 Oct;30(10):2593-8. Epub 2007 Jul 13.PMID: 17630264 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Diabetes in urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes.

    Goldschmid MG, Domin WS, Ziemer DC, Gallina DL, Phillips LS.

    Diabetes Care. 1995 Jul;18(7):955-61.PMID: 7555556 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).

    Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G; DAIS Investigators.

    Am J Kidney Dis. 2005 Mar;45(3):485-93.PMID: 15754270 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

    Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE; Diabetes Prevention Program Research Group.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. Epub 2008 Sep 30.PMID: 18826999 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]

    Flórez H.

    Invest Clin. 1997 Mar;38(1):39-52. Review. Spanish. PMID: 9235072 [PubMed - indexed for MEDLINE]Related articles

    13.

    Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes.

    Schultz CJ, Neil HA, Dalton RN, Dunger DB; Oxforn Regional Prospective Study Group.

    Diabetes Care. 2000 Dec;23(12):1811-5.PMID: 11128358 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan.

    Tseng CH.

    Kidney Int. 2005 Aug;68(2):796-801.PMID: 16014058 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Progress in the prevention of type 2 diabetes]

    Schernthaner G.

    Wien Klin Wochenschr. 2003 Nov 28;115(21-22):745-57. Review. German. PMID: 14743578 [PubMed - indexed for MEDLINE]Related articles

    16.

    Targeting albumin excretion rate in the treatment of the hypertensive diabetic patient with renal disease.

    Krimholtz MJ, Karalliedde J, Thomas S, Bilous R, Viberti G.

    J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S42-7.PMID: 15938033 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants.

    Rubin RR, Knowler WC, Ma Y, Marrero DG, Edelstein SL, Walker EA, Garfield SA, Fisher EB; Diabetes Prevention Program Research Group.

    Diabetes Care. 2005 Apr;28(4):830-7.PMID: 15793181 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

    Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Apr 19;142(8):611-9.PMID: 15838067 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM.

    Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS.

    Diabetes Care. 1995 Jul;18(7):1013-6.PMID: 7555533 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data